膜型ループス腎炎に対するシクロスポリンを含む4薬併用療法

Saved in:
Bibliographic Details
Published in日本腎臓学会誌 Vol. 45; no. 7; pp. 689 - 694
Main Authors 岡田, 知也, 岩澤, 秀明, 長岡, 由女, 外丸, 良, 中尾, 俊之, 松本, 博, 和田, 憲和
Format Journal Article
LanguageJapanese
Published 社団法人 日本腎臓学会 25.10.2003
Online AccessGet full text
ISSN0385-2385
1884-0728
DOI10.14842/jpnjnephrol1959.45.689

Cover

Author 松本, 博
中尾, 俊之
岡田, 知也
長岡, 由女
外丸, 良
岩澤, 秀明
和田, 憲和
Author_xml – sequence: 1
  fullname: 岡田, 知也
  organization: 東京医科大学腎臓科
– sequence: 1
  fullname: 岩澤, 秀明
  organization: 東京医科大学腎臓科
– sequence: 1
  fullname: 長岡, 由女
  organization: 東京医科大学腎臓科
– sequence: 1
  fullname: 外丸, 良
  organization: 東京医科大学腎臓科
– sequence: 1
  fullname: 中尾, 俊之
  organization: 東京医科大学腎臓科
– sequence: 1
  fullname: 松本, 博
  organization: 東京医科大学腎臓科
– sequence: 1
  fullname: 和田, 憲和
  organization: 東京医科大学腎臓科
BookMark eNpdkM1Kw0AUhQdRsNY-g0-QOpPMTGaWUvzDgiC6DtN0YhtqWpJu3NkJuikUEX8oqGuxShdFRFBf5lrbxzBQceHmu9xzD5fDWULzUTPSCK0QXCRUUHs1bEVhpFu1uNkgkskiZUUu5BzKESGohV1bzKMcdgSz7AyLqJAk9QomwsUOc2kO7U3Pbsf3XUgHkL5DegPmbXram5gedAbj4Sd0-mC6YF7BDCF9zq6Q3kH6COkIzMX4fADmhE6vn74-XiaXD5O--R5dLaOFQDUSXfideXSwsb5f2rLKu5vbpbWyFRImlGUHGPOgattKVmwifcY0oVk0zTjmPsZOprJsd7kIfM60JMwlDiU-rTpY8sDJo53Z3zBpq0PtteL6kYqPPRW3635De_-q8Sjz3Bmyhv5cfk3FXqicH77BgCo
ContentType Journal Article
Copyright 社団法人日本腎臓学会
Copyright_xml – notice: 社団法人日本腎臓学会
DOI 10.14842/jpnjnephrol1959.45.689
DeliveryMethod fulltext_linktorsrc
EISSN 1884-0728
EndPage 694
ExternalDocumentID article_jpnjnephrol1959_45_7_45_7_689_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
JSF
KQ8
OK1
RJT
ID FETCH-LOGICAL-j158a-2f006fd22a9b219c55e14b01e5606c003b215b01768fc65e91571341c4d3096f3
ISSN 0385-2385
IngestDate Wed Sep 03 05:55:43 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 7
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j158a-2f006fd22a9b219c55e14b01e5606c003b215b01768fc65e91571341c4d3096f3
OpenAccessLink https://www.jstage.jst.go.jp/article/jpnjnephrol1959/45/7/45_7_689/_article/-char/ja
PageCount 6
ParticipantIDs jstage_primary_article_jpnjnephrol1959_45_7_45_7_689_article_char_ja
PublicationCentury 2000
PublicationDate 2003/10/25
PublicationDateYYYYMMDD 2003-10-25
PublicationDate_xml – month: 10
  year: 2003
  text: 2003/10/25
  day: 25
PublicationDecade 2000
PublicationTitle 日本腎臓学会誌
PublicationTitleAlternate 日腎会誌
PublicationYear 2003
Publisher 社団法人 日本腎臓学会
Publisher_xml – name: 社団法人 日本腎臓学会
References 16. Shapia Y, Mor F, Freidler A, Wysenbeek AJ, Weinberger A. Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome. Ann Rheum Dis 1990 ; 49 : 725-727.
21. Chishti AS, Sorof JM, Brewer ED, Kale A. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis 2001 ; 38 : 754-760.
14. Radhakrishnan J, Kunis CL, D'Agati V, Appcl GB. Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 1994 ; 42 :147 154.
11. Pasquali S, Banfi G, Zucchelli A, Moroni G, Ponticelli C, Zucchelli P. Lupus membranous nephropathy : long-term outcome. Clin Nephrol 1993 ; 39 :175-182.
20. Meyrier A, Noel LH, Ariche P, Collard P, Collaborative Group of the Societe de Nephrologie. Long-term renal tolerance of cyclosporin A treatment in adult nephrosis. Kidney Int 1994 ; 45 :1446-1456.
1. Donadio JV, Burgess JH, Holly KE. Membranous lupus nephropathy : a clinicopathologic study. Medicine 1977 ; 56 : 527-536.
2. Friend PS, Kim Y, Michael AF, Donadio JV. Pathogenesis of membranous lupus nephropathy in systemic lupus eryth ematosus : possible role of nonprecipitating DNA antibody. Br Med J 1977 ; 1 : 25.
18. Ishikawa A, Fujita K, Suzuki K. The influence of temocapril, an angiotensin converting enzyme inhibitor, on the cyclosporine-induced nephrotoxity. J Urol 1997 ; 157: 739-742.
22. Einecke G, Mai I, Diekmann F, Fritsche L, Neumayer HH, Budde K. Cyslosporine absorption profiling and therapeutic drug monitoring using C2 blood levels in stable renal allograft recipients. Transplant Proceed 2002 ; 34 : 1738-1739.
15. Tokuda M, Kurata N, Mizoguchi A, Inoh M, Seto K. Kinashi M, Takahara J. Effect of low-dose cyclosporin A on systemic lupus erythmatosus disease activity. Arthritis Rheum 1994 ; 37 : 551-558.
19. Feutren G, Mihatsch MJ. For the International Kidney Biopsy Registry of Cyclosporine in Autoimmune Disease Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992 ;326 :1654-1660.
12. Chan TM, Li FK, Hao WK, Chan KW, Lui SL, Tang S. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression. Lupus 1999 ; 8 : 545-551.
7. Baldwin DS, Gluck MC, Lowenstein J, Gallo GR. Lupus nephritis. Clinical course as related to morphologic forms and their transitions. Am J Med 1977 ; 62 : 12-30.
5. Boumpas DT, Austin HA III, Vaughan EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JF. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992 ; 340 : 741-745.
9. 槇野博史,山崎康司,林 義和,原本俊則,四方賢一,熊谷功,谷合一陽,高橋香代,太田善介.ループス腎炎に対するメチルプレドニゾロンパルス療法の組織型よりみた効果.日腎会誌1990;32:791-799.
13. Cattran DC, Greenwood C, Ritchie S, Bernstein K, Churchill DN, Clark WF, Marrin PA, Lavoie S. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney lnt 1995 ; 47 : 1130-1135.
8. 市川陽一,斉藤栄造,阿部好文,鈴木康夫.ステロイド剤のパルス療法.最新医学1980;35:1379-1386.
17. Nakano M, Ueno M, Hasegawa H, Watanabe T, Kuroda T, Ito S, Arakawa M. Renal haemodynamics in patients with lupus nephritis. Ann Rheum Dis 1998 ; 57 : 226-230.
4. Mercadal L, du Montcel ST, Nochy D, Queffeulou G, Piette JC, Isnard-Bagnis C, Martinez F, the Groupe d'Etudes Nephrologiques en lie de France. Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 2002 ; 17 :1771 -1778.
3. Kolasinski SL, Chung JB, Albert DA. What do we know about lupus membranous nephropathy? An analytic review. Arthritis Rheum 2002 ; 47 : 450-455.
6. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on PrognosisStudies in SLE. Arthritis Rheum 1992 ; 35 : 630-640.
10. Moroni G, Maccario M, Banfi G, Quaglini S, Ponticelli C, FRCP. Treatment of membranous lupus nephritis. Am J Kidney Dis 1998 ; 31: 681-686.
References_xml – reference: 14. Radhakrishnan J, Kunis CL, D'Agati V, Appcl GB. Cyclosporine treatment of lupus membranous nephropathy. Clin Nephrol 1994 ; 42 :147 154.
– reference: 21. Chishti AS, Sorof JM, Brewer ED, Kale A. Long-term treatment of focal segmental glomerulosclerosis in children with cyclosporine given as a single daily dose. Am J Kidney Dis 2001 ; 38 : 754-760.
– reference: 10. Moroni G, Maccario M, Banfi G, Quaglini S, Ponticelli C, FRCP. Treatment of membranous lupus nephritis. Am J Kidney Dis 1998 ; 31: 681-686.
– reference: 12. Chan TM, Li FK, Hao WK, Chan KW, Lui SL, Tang S. Treatment of membranous lupus nephritis with nephrotic syndrome by sequential immunosuppression. Lupus 1999 ; 8 : 545-551.
– reference: 2. Friend PS, Kim Y, Michael AF, Donadio JV. Pathogenesis of membranous lupus nephropathy in systemic lupus eryth ematosus : possible role of nonprecipitating DNA antibody. Br Med J 1977 ; 1 : 25.
– reference: 3. Kolasinski SL, Chung JB, Albert DA. What do we know about lupus membranous nephropathy? An analytic review. Arthritis Rheum 2002 ; 47 : 450-455.
– reference: 7. Baldwin DS, Gluck MC, Lowenstein J, Gallo GR. Lupus nephritis. Clinical course as related to morphologic forms and their transitions. Am J Med 1977 ; 62 : 12-30.
– reference: 20. Meyrier A, Noel LH, Ariche P, Collard P, Collaborative Group of the Societe de Nephrologie. Long-term renal tolerance of cyclosporin A treatment in adult nephrosis. Kidney Int 1994 ; 45 :1446-1456.
– reference: 11. Pasquali S, Banfi G, Zucchelli A, Moroni G, Ponticelli C, Zucchelli P. Lupus membranous nephropathy : long-term outcome. Clin Nephrol 1993 ; 39 :175-182.
– reference: 19. Feutren G, Mihatsch MJ. For the International Kidney Biopsy Registry of Cyclosporine in Autoimmune Disease Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992 ;326 :1654-1660.
– reference: 6. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on PrognosisStudies in SLE. Arthritis Rheum 1992 ; 35 : 630-640.
– reference: 9. 槇野博史,山崎康司,林 義和,原本俊則,四方賢一,熊谷功,谷合一陽,高橋香代,太田善介.ループス腎炎に対するメチルプレドニゾロンパルス療法の組織型よりみた効果.日腎会誌1990;32:791-799.
– reference: 18. Ishikawa A, Fujita K, Suzuki K. The influence of temocapril, an angiotensin converting enzyme inhibitor, on the cyclosporine-induced nephrotoxity. J Urol 1997 ; 157: 739-742.
– reference: 1. Donadio JV, Burgess JH, Holly KE. Membranous lupus nephropathy : a clinicopathologic study. Medicine 1977 ; 56 : 527-536.
– reference: 13. Cattran DC, Greenwood C, Ritchie S, Bernstein K, Churchill DN, Clark WF, Marrin PA, Lavoie S. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Canadian Glomerulonephritis Study Group. Kidney lnt 1995 ; 47 : 1130-1135.
– reference: 17. Nakano M, Ueno M, Hasegawa H, Watanabe T, Kuroda T, Ito S, Arakawa M. Renal haemodynamics in patients with lupus nephritis. Ann Rheum Dis 1998 ; 57 : 226-230.
– reference: 4. Mercadal L, du Montcel ST, Nochy D, Queffeulou G, Piette JC, Isnard-Bagnis C, Martinez F, the Groupe d'Etudes Nephrologiques en lie de France. Factors affecting outcome and prognosis in membranous lupus nephropathy. Nephrol Dial Transplant 2002 ; 17 :1771 -1778.
– reference: 5. Boumpas DT, Austin HA III, Vaughan EM, Klippel JH, Steinberg AD, Yarboro CH, Balow JF. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992 ; 340 : 741-745.
– reference: 8. 市川陽一,斉藤栄造,阿部好文,鈴木康夫.ステロイド剤のパルス療法.最新医学1980;35:1379-1386.
– reference: 16. Shapia Y, Mor F, Freidler A, Wysenbeek AJ, Weinberger A. Antiproteinuric effect of captopril in a patient with lupus nephritis and intractable nephrotic syndrome. Ann Rheum Dis 1990 ; 49 : 725-727.
– reference: 22. Einecke G, Mai I, Diekmann F, Fritsche L, Neumayer HH, Budde K. Cyslosporine absorption profiling and therapeutic drug monitoring using C2 blood levels in stable renal allograft recipients. Transplant Proceed 2002 ; 34 : 1738-1739.
– reference: 15. Tokuda M, Kurata N, Mizoguchi A, Inoh M, Seto K. Kinashi M, Takahara J. Effect of low-dose cyclosporin A on systemic lupus erythmatosus disease activity. Arthritis Rheum 1994 ; 37 : 551-558.
SSID ssib018703574
ssib004261733
ssib058493074
ssib000833381
ssib002004354
ssib005879731
ssib039893136
ssib008531636
ssib038076193
ssj0000696431
ssib000940323
ssib002822005
ssib038586121
ssib047305546
Score 1.6218436
SourceID jstage
SourceType Publisher
StartPage 689
Title 膜型ループス腎炎に対するシクロスポリンを含む4薬併用療法
URI https://www.jstage.jst.go.jp/article/jpnjnephrol1959/45/7/45_7_689/_article/-char/ja
Volume 45
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本腎臓学会誌, 2003/10/25, Vol.45(7), pp.689-694
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrR1Na9RANJR68SJKFb_pwTlJ6iYzk5k5JrtZqqIHaaG3ZZNNDotsRdqLJ5tFL4Ui4gcF9SxW6aGICOqfGWv7M3xvJsmmtQctwhLm4703b97L7Lw3mXnjONcokxh1qu8mPM1cphLh9nMhQCEpl2rgy1aKC_p37gbzi-zWEl-amp5p7FpaXUnm0kdHnis5jlahDPSKp2T_QbM1USiANOgXnqBheP6VjkksiQyIapOYExUTGZGYEklJWCWidplQwiR8EimDxYmMSSywBBNQ5RksTsIuiaoSpUqskjKgV3QArGyr06Bs2-pUVWHFBi1hlG9YbVUc4k4LhgypgITAKyNRh0QcOVOMhNIkFMLFAVKxV2VW1jQWQsdCbhJtQ6HuGyQAl5oudUgYGOJtokKsAs5kvT6MIBH0yCubjVr44plM1xBn2DfVPQyvDFMxCVkFHwrcOYLMQOvxBB6wuRFd1VBFHyh7hkOooE36QFNZliX-DDzQVCD3Aws1ZsufPdRthpbhghkNgpwjEtJacoZaCL_rx5NbY86gkrtghdlmMzunScnclijP4JeTno3hWQ5u0ZjBAnujU2kMBfYG6j_mWSYZBu4dPhgNRxn86yzfxyBFc4zP1fgHgpiXQ6R3CKHHeE_YB-D1Kig8cNgbgtdzwhfCbr64ebvpNFDaPD2uWIs2jXj8ut0MEgg28KE7GTzRcHK4FHh_W50HAxaclNpI92BGo3ziJOENDYE3mdXwyzqG4avzClwAb4LPBAbVmyy6gMWvaBWBytqLGBPPXO1Zaa_ciIpSvnG0jMFgHoL7WG09NdbwwmnnVOnGzoZWlGecqWF_xrm3__TN7rt1Pd7S4296_FoXX_efbOwVG3pta3f7h17b1MW6Lr7oYluPP0GtHr_V4w96vKOL57vPtnTxmO2_-vjz--e9F-_3NotfOy_POovdeKE975Z3trhDj8u-6-fQn3zg-32VgDGUcp55DISYgWcVpDAqoJRDXgQyTwOeKY_jaXYvZQPaUkFOzznTo-VRdt6ZDVju9fMkSfMMLI3Ulwk4s2mSJDQF4nRwwelYEfQe2MA8vWO9ZRf_D5lLzsnJoL_sTK88XM2ugL-yklw1r-9vX0z_eA
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E8%86%9C%E5%9E%8B%E3%83%AB%E3%83%BC%E3%83%97%E3%82%B9%E8%85%8E%E7%82%8E%E3%81%AB%E5%AF%BE%E3%81%99%E3%82%8B%E3%82%B7%E3%82%AF%E3%83%AD%E3%82%B9%E3%83%9D%E3%83%AA%E3%83%B3%E3%82%92%E5%90%AB%E3%82%804%E8%96%AC%E4%BD%B5%E7%94%A8%E7%99%82%E6%B3%95&rft.jtitle=%E6%97%A5%E6%9C%AC%E8%85%8E%E8%87%93%E5%AD%A6%E4%BC%9A%E8%AA%8C&rft.au=%E5%B2%A1%E7%94%B0%2C+%E7%9F%A5%E4%B9%9F&rft.au=%E5%B2%A9%E6%BE%A4%2C+%E7%A7%80%E6%98%8E&rft.au=%E9%95%B7%E5%B2%A1%2C+%E7%94%B1%E5%A5%B3&rft.au=%E5%A4%96%E4%B8%B8%2C+%E8%89%AF&rft.date=2003-10-25&rft.pub=%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E8%85%8E%E8%87%93%E5%AD%A6%E4%BC%9A&rft.issn=0385-2385&rft.eissn=1884-0728&rft.volume=45&rft.issue=7&rft.spage=689&rft.epage=694&rft_id=info:doi/10.14842%2Fjpnjnephrol1959.45.689&rft.externalDocID=article_jpnjnephrol1959_45_7_45_7_689_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0385-2385&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0385-2385&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0385-2385&client=summon